Longitudinal assessment of neuropsychological function in major depression

Abstract

Neuropsychological impairment is a core component of major depression, yet its relationship to clinical state is unclear. The aims of the present review were to determine which neuropsychological domains and tasks were most sensitive to improvement in clinical state in major depression and to highlight the methodological issues in such research. Studies that included a baseline and at least one follow-up neuropsychological testing session in adults with major depression were identifed using MEDLINE, Web of Science and ScienceDirect databases. Thirty studies were included in the review. Findings in younger adult populations suggested that improvement in mood was most strongly related to improved verbal memory and verbal fluency, while measures of executive functioning and attention tended to remain impaired across treatment. In late-life major depression, improved psychomotor speed was most closely related to treatment response, but there was much inconsistency between study findings, which may be due to methodological issues. In major depression, particular neuropsychological domains are more strongly related to clinical state than others. The findings from the present review suggest that the domains most sensitive to clinical state are verbal learning and memory, verbal fluency and psychomotor speed. In contrast, measures of attention and executive functioning perhaps represent more trait-like markers of major depression. With further methodologically sound research, the changes in neuropsychological function associated with treatment response may provide a means of evaluating different treatment strategies in major depression.

Key words::

• executive function
• major depressive disorder
• memory
• neuropsychological function
• remission

• Zakzanis K, Leach L, Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11:111–119.
   PubMedGoogle Scholar
• Porter RJ, Douglas K, Knight RG. Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice. J ECT2008; 24:25–34.
   PubMed Web of Science ®Google Scholar
• Biringer E, Mykletun A, Sundet K, Kroken R, Stordal KI, Lund A. A longitudinal analysis of neurocognitive function in unipolar depression. J Clin Exp Neuropsychol 2007; 29(8):1–13.
   PubMed Web of Science ®Google Scholar
• Portella MJ, Marcos T, Rami L, Navarro V, Gasto C, Salamero M. Residual cognitive impairment in late-life depression after a 12-month period follow-up. Int J Geriatr Psychiatry 2003; 18:571–576.
   PubMed Web of Science ®Google Scholar
• Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res 2006; 145:39–48.
   PubMed Web of Science ®Google Scholar
• Majer M, Ising M, Kunzel H . Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychol Med 2004; 34:1453–1463.
   PubMed Web of Science ®Google Scholar
• Reppermund S, Ising M, Lucae S, Zihl J. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med 2009; 39:603–614.
   PubMed Web of Science ®Google Scholar
• Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004; 29:1538–1545.
   PubMed Web of Science ®Google Scholar
• Savaskan E, Muller SE, Bohringer A, Schulz A, Schachinger H. Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients. Int J Neuropsychopharmacol 2008; 11:381–388.
   PubMed Web of Science ®Google Scholar
• Vythilingam M, Vermetten E, Anderson GM . Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004; 56:101–112.
   PubMed Web of Science ®Google Scholar
• Wroolie TE, Williams KE, Keller J . Mood and neuropsycho-logical changes in women with midlife depression treated with escitalopram. J Clin Psychopharmacol 2006; 26:361–366.
   PubMed Web of Science ®Google Scholar
• Abas MA, Sahakian BJ, Levy R. Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med 1990; 20:507–520.
   PubMed Web of Science ®Google Scholar
• Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996; 26:591–603.
   PubMed Web of Science ®Google Scholar
• Bhalla RK, Butters MA, Mulsant BH . Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry 2006; 14:419–427.
   PubMed Web of Science ®Google Scholar
• Butters MA, Becker JT, Nebes RD . Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000; 157:1949–1954.
   PubMed Web of Science ®Google Scholar
• Lee JS, Potter GG, Wagner HR, Welsh-Bohmer KA, Steffens DC. Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatr 2007; 19:125–135.
   PubMed Web of Science ®Google Scholar
• Gallassi R, Di Sarro R, Morreale A, Amore M. Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord 2006; 91:243–250.
   PubMed Web of Science ®Google Scholar
• Nebes RD, Butters MA, Mulsant BH . Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med 2000; 30:679–691.
   PubMed Web of Science ®Google Scholar
• Nebes RD, Pollock BG, Houck PR . Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003; 37:99–108.
   PubMed Web of Science ®Google Scholar
• O’Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004; 161:2081–2090.
   PubMed Web of Science ®Google Scholar
• Biringer E, Lundervold A, Stordal K . Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiatry Clin Neurosci 2005; 255:373–380.
   PubMed Web of Science ®Google Scholar
• Beblo T, Baumann B, Bogerts B, Wallesch C, Herrmann M. Neuropsychological correlates of major depression: a short-term follow-up. Cogn Neuropsychiatry 1999; 4:333–341.
   Google Scholar
• Gallagher P, Robinson LJ, Gray JM, Porter RJ, Young AH. Neurocognitive function following remission in major depressive disorder: potential objective marker of response? Aust N Z J Psychiatry 2007; 41:54–61.
   PubMed Web of Science ®Google Scholar
• Reppermund S, Zihl J, Lucae S . Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 2007; 62:400–406.
   PubMed Web of Science ®Google Scholar
• Zobel AW, Schulze-Rauschenbach S, von Widdern OC . Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. J Psychiatr Res 2004; 38:377–383.
   PubMed Web of Science ®Google Scholar
• Butters MA, Bhalla RK, Mulsant BH . Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late–life depression: is there a relationship? Am J Geriatr Psychiatry 2004; 12:387–394.
   PubMed Web of Science ®Google Scholar
• Devanand DP, Pelton GH, Marston K . Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 2003; 18:123–130.
   PubMed Web of Science ®Google Scholar
• Herrera-Guzman I, Gudayol-Ferre E, Lira-Mandujano J . Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Res 2008; 160:72–82.
   PubMed Web of Science ®Google Scholar
• Constant EL, Adam S, Gillain B, Seron X, Bruyer R, Seghers A. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depress Anxiety 2005; 21:78–89.
   PubMed Web of Science ®Google Scholar
• Neu P, Kiesslinger U, Schlattmann P, Reischies FM. Time-related cognitive deficiency in four different types of depression. Psychiatry Res 2001; 103:237–247.
   PubMed Web of Science ®Google Scholar
• Trichard C, Martinot JL, Alagille M . Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study. Psychol Med 1995; 25:79–85.
   PubMed Web of Science ®Google Scholar
• Doraiswamy PM, Krishnan KR, Oxman T . Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol Series A 2003; 58:M1137–1144.
   PubMed Web of Science ®Google Scholar
• Lezak M, Howieson D, Loring D. Neuropsychological assessment, 4th New York: Oxford University Press, 2004.
   Google Scholar
• Paelecke-Habermann Y, Pohl J, Leplow B. Attention and executive functions in remitted major depression patients. J Affect Disord 2005; 89:125–135.
   PubMed Web of Science ®Google Scholar
• Weiland-Fiedler P, Erickson K, Waldeck T . Evidence for continuing neuropsychological impairments in depression. J Affect Disord 2004; 82:253–258.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Muir WJ, Blackwood DH. Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disord 2006; 8: 40–46.
   PubMed Web of Science ®Google Scholar
• Christensen MV, Kyvik KO, Kessing LV. Cognitive function in unaffected twins discordant for affective disorder. Psychol Med 2006; 36:1119–1129.
   PubMed Web of Science ®Google Scholar
• Rocca P, Calvarese P, Faggiano F . Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial. J Clin Psychiatry 2005; 66:360–369.
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Gallagher P, Robinson LJ . A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med 2009; 39:725–733.
   PubMed Web of Science ®Google Scholar
• Gorwood P, Corruble E, Falissard B, Goodwin GM. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry 2008; 165:731–739.
   PubMed Web of Science ®Google Scholar
• Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004; 161: 1957–1966.
   PubMed Web of Science ®Google Scholar
• Tarbuck AF, Paykel ES. Effects of major depression on the cognitive function of younger and older subjects. Psychol Med 1995; 25:285–295.
   PubMed Web of Science ®Google Scholar
• Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am J Psychiatry 2002; 159: 1119–1126.
   PubMed Web of Science ®Google Scholar
• Weiss EM, Kemmler G, Deisenhammer EA, Fleischhacker WW, Delazer M. Sex differences in cognitive functions. Pers Individ Differ 2003; 35:863–875.
   Web of Science ®Google Scholar
• Reitan RM, Wolfson D. Influence of age and education on neuropsychological test results. Clin Neuropsychol 1995; 9:151–158.
   Web of Science ®Google Scholar
• Symonds CS, Gallagher P, Thompson JM, Young AH. Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women. Psychol Med 2004; 34:93–102.
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Park S. Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 2002; 27:835–841.
   PubMed Web of Science ®Google Scholar
• Porter RJ, Bourke C, Gallagher P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 2007; 41:115–128.
   PubMed Web of Science ®Google Scholar
• Siepmann M, Grossmann J, Muck-Weymann M, Kirch W. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 2003; 168:293–298.
   PubMed Web of Science ®Google Scholar
• Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003; 182:214–220.
   PubMed Web of Science ®Google Scholar
• Fairweather D, Kerr J, Harrison D, Moon C, Hindmarch I. A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993; 8:41–47.
   Web of Science ®Google Scholar
• Richardson J, Keegan D, Bowen R . Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. Int Clin Psychopharmacol 1994; 9:35–40.
   PubMed Web of Science ®Google Scholar
• Gomez RG, Fleming SH, Keller J . The neuropsychological profile of psychotic major depression and its relation to cortisol. Biol Psychiatry 2006; 60:472–478.
   PubMed Web of Science ®Google Scholar
• Christensen H, Griffiths K, Mackinnon A, Jacomb P. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 1997; 3:631–651.
   PubMedGoogle Scholar
• Lloyd AJ, Ferrier IN, Barber R, Gholkar A, Young AH, O’Brien JT. Hippocampal volume change in depression: late- and early-onset illness compared. Br J Psychiatry 2004; 184:488–495.
   PubMed Web of Science ®Google Scholar
• Surguladze SA, Young AW, Senior C, Brebion G, Travis MJ, Phillips ML. Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 2004; 18:212–218.
   PubMed Web of Science ®Google Scholar
• Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: The Guilford Press, 1979.
   Google Scholar
• Lawrence NS, Williams AM, Surguladze S . Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 2004; 55:578–587.
   PubMed Web of Science ®Google Scholar
• Harmer CJ. Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 2008; 55:1023–1028.
   PubMed Web of Science ®Google Scholar
• Venn HR, Watson S, Gallagher P, Young AH. Facial expression perception: an objective outcome measure for treatment studies in mood disorders? Int J Neuropsychopharmacol 2006; 9:229–245.
   PubMed Web of Science ®Google Scholar
• Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM. Acxute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003; 28:148–152.
   PubMed Web of Science ®Google Scholar